- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/427 - Thiazoles not condensed and containing further heterocyclic rings
Patent holdings for IPC class A61K 31/427
Total number of patents in this class: 3804
10-year publication summary
|
287
|
287
|
236
|
269
|
274
|
267
|
299
|
246
|
194
|
58
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Novartis AG | 11238 |
67 |
| Merck Sharp & Dohme LLC | 3689 |
58 |
| F. Hoffmann-La Roche AG | 7958 |
52 |
| Takeda Pharmaceutical Company Limited | 2961 |
50 |
| Bristol-myers Squibb Company | 5080 |
45 |
| Daiichi Sankyo Company, Limited | 1829 |
44 |
| Dana-Farber Cancer Institute, Inc. | 2455 |
37 |
| Boehringer Ingelheim International GmbH | 4629 |
36 |
| The Regents of the University of California | 18943 |
35 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2737 |
35 |
| Janssen Pharmaceutica N.V. | 3839 |
33 |
| Gilead Sciences, Inc. | 1879 |
33 |
| Astellas Pharma Inc. | 1145 |
31 |
| Vertex Pharmaceuticals Incorporated | 1581 |
30 |
| Shionogi & Co., Ltd. | 914 |
29 |
| Abbvie Inc. | 1808 |
28 |
| Genentech, Inc. | 3742 |
26 |
| EyePoint Pharmaceuticals, Inc. | 100 |
26 |
| Pfizer Inc. | 3322 |
21 |
| Hoffmann-La Roche Inc. | 3060 |
20 |
| Other owners | 3068 |